Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nitric oxide is effective in the treatment
of acute kidney injury in cardiac surgical patients with sign and laboratory data suggesting
endothelial dysfunction undergoing prolonged cardiopulmonary bypass.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Bonventre, Joseph V., M.D., Brigham Women Hospital Fisher, Daniel, R.R.T., Massachusetts General Hospital Ichinose, Fumito, M.D., Ph.D., Massachusetts General Hospital Kacmarek, Robert M., Ph.D., Massachusetts General Hospital Kenneth, Shelton, M.D., Massachusetts General Hospital Marrazzo, Francesco, M.D., Massachusetts General Hospital National Heart, Lung, and Blood Institute (NHLBI) Rezoagli, Emanuele, M.D., Massachusetts General Hospital Roy, Nathalie, M.D., Massachusetts General Hospital Shann, Kenneth G., Massachusetts General Hospital Spina, Stefano, M.D., Massachusetts General Hospital Sundt, Thoralf M., M.D., Massachusetts General Hospital Thompson, Boyd Taylor, M.D., Massachusetts General Hospital Villavicencio-Theoduloz, Mauricio A., M.D., Massachusetts General Hospital Zadek, Francesco, M.D., Massachusetts General Hospital Zapol, Warren M., M.D.